GREY:IPHAF - Post by User
Comment by
BornReady1970on Jun 25, 2010 4:47pm
394 Views
Post# 17223221
RE: Data driven
RE: Data drivenThere are two types of data:
Clinical - ISA has good clinical data. I don't think there is anyone on this board that has ever effectively shot holes in Volco, and most are very positive on the drug.
Business - ISA has taken a very promising drug and managed to move it's share price from over $5.00 to
.25. That is real data. ISA has publicaly disclosed that it has cash flow until Q4 of 2010. That is real data.
Any ISA investor has to answer one very simple question...
Will good clinical data overcome poor business data? If you think so then BUY; if not then SELL.
If you want to hedge, the only hedge available is to buy Paladin. With Paladin you get both good clinical data and good busniess data.
I still think the share price will settle out under
.20 before we get any more news.